Menu
Advamedica has developed a “Protonated Bio adhesive Technology” under the name of Axiostat, which is a bioactive hemostatic dressing. It works on a unique charge-based mechanism of mucoadhesion which forms a mechanical barrier on the bleeding site.
Axiostat, based on their Chitosan is considered as one of the most promising biomaterial of 21st century due to its versatile nature, excellent biodegradability, biocompatibility, antimicrobial activity, non-toxicity, and wide applications.
*Axiostat uses Protonated Bioadhesive Technology developed by Advamedica and is available in 40+ countries.
For more info, visit axiostatusa.com
Accomplished Medical Sales Professional with a 20 year record of growing markets, increasing product penetration and leading high performance sales teams in hemostat business. Previously Phil was Vice President at Core Scientific and spent a decade at ZMedica, a leading hemostat company as Regional Sales Director. Phil has a business management degree from Florida State University.
Dr. Mahadevan is a Professor of Emergency Medicine at Stanford University where he has been a recipient of numerous teaching awards. He also serves as the Director of Global Affairs and Strategy for Stanford Medicine. He received his medical degree from David Geffen School of Medicine at UCLA.
Dr. Sengupta serves as the Associate Professor of Medicine at HMS and as the Associate Professor of Health Sciences and Technology at MIT. Dr. Sengupta received his PhD from University of Cambridge as a British Chevening and Nehru Scholar, and is a recipient of the TR35 Innovator Award from the MIT Technology Review Magazine and the Era of Hope Scholar Award from the US Department of Defense.
Satish brings a wealth of diverse experiences to his CFO role at Advamedica. In addition to his Fortune 500 roles (FedEx, Citi, AmEx, JPM Chase) in various leadership capacities across multiple countries, he has worked with a number of startups and SMBs as their in-house or consulting CFO. Over the last three years, Satish has helped companies raise over $100 million in venture capital and financing.
Quality professional with over 25 years of experience in the medical device, pharmaceutical, and software industries.
Maria is specialized in developing and implementing Quality Management Systems and has deep knowledge and experience in audit preparation, resolution/remediation as per regulatory compliance in ISO 13485, 21 CFR Part 820, EU MDR, MDSAP, and other regional regulations (China, Taiwan, Brazil, Japan, Canada, Australia, Korea, Switzerland, etc.)
Samantha is Director of Clinical Marketing at Advamedica. Previously she was Global Training Manager in Terumo Aortic overseeing all training and clinical skills. Prior to that Samantha was National Sales & Marketing Manager in Bolton Medical, Italy for almost a decade. Samantha has done Executive MBA in Strategic Marketing and has Degree in Professional nursing from the University of Bologna, Italy.
Edward is US – National Sales Director at Advamedica. He comes with many decades of experience selling novel hemostats and woundcare products in over 26 states in the US. He was earlier Regional Sales Director at Z-Medica managing business of their Hemostatic product line for Surgery, Trauma, Cardiology, Burn and Wound Care. He is passionate about creating top performing teams, driven by diversity, inclusion, values and accountability. Edward has a Bachelor of Business Administration from Dowling College.
Oscar Rospigliosi is a Senior MedTech executive with broad experience in medical device sales and marketing. He was the CEO & Director at Scion Biomedical and prior to that, he was a CEO at Bolton Medical Group, guiding the company from $4.5mn in annual revenues to $80mn in the cardio-thoracic market.
Leo Mavely is the president of Advamedica Inc. He is passionate about medtech innovations for unmet healthcare needs, and has been featured by Fortune Magazine in 40 under 40 business leaders and by Entrepreneur Magazine in 35 under 35 Game-Changing Entrepreneurs. He holds a Bachelor’s degree in Bioengineering.
